Coronavirus. Covid-19
Conditions
Interventions
Intervention 1: Intervention group: Herbal product including methanolic extract of seeds and propolis is prepared in the form of 60 cc syrup and this amount of syrup is prepared for two days of the pa
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Acute respiratory labeling (ARI) with 2-fold reduction under control: RR> 30; 80% <PO2 <93%; Chest floor Pulmonary infiltration; Clinical judgment of a specialist Age range 18 to 85 years of both sexes The patient does not have any serious concurrent cardiovascular and cerebral diseases The patient's ability and personal desire to fill out a personal consent form to enter the study
Exclusion criteria
Exclusion criteria: History of heart disease, mental disease and pregnant women Existence of any history of allergy to any of the components of the herbal product Nausea and vomiting and intolerance to food Resistant hypoxemia and decreased level of consciousness Hemodynamic instability Hypercapnia - Respiratory fatigue
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The comparison of the symptoms such as fever, dry cough, diarrhea, vomiting, sore throat, sore throat and larynx, abdominal pain and chest pain, nausea, chills and anorexia. Timepoint: The hypotheses are tested at the beginning of the study and on the second, fourth, and sixth days of treatment. Method of measurement: Questionnaire and observation.;Comparison of blood factors CBC, ESR and CRP. Timepoint: The hypotheses are tested at the beginning of the study and on the second, fourth, and sixth days of treatment. Method of measurement: Biochemical factors measured in a clinical laboratory.;Comparison of heart rate, blood pressure and body temperature. Timepoint: The hypotheses are tested at the beginning of the study and on the second, fourth, and sixth days of treatment. Method of measurement: Pressure gauge and thermometer.;Comparison of respiration rate per minute, percentage of blood oxygen saturation and number of days requiring adjuvant oxygen therapy. Timepoint: The hypotheses are tested at the beginning of the study and on the second, fourth, and sixth days of treatment. Method of measurement: Pulse Oximeter.;Evaluation of drug side effects. Timepoint: Days of the first, second and fourth, sixth days after the start of treatment between the intervention and control groups. Method of measurement: View and questionnaire and .;Comparison of the status of withdrawal from the continuation of the study. Timepoint: After starting treatment between the intervention and control groups. Method of measurement: View and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMorteza Kosari
Kashan University of Medical Sciences
Outcome results
None listed